ecancer

Establishing immunotherapy as a standard in cancer treatment

Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA

18 Jul 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

11 Jul 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

The problem of unnecessary treatment of prostate cancer

Dr Rosalind Eeles - Royal Marsden Hospital, London, UK

3 Jun 2013

Racial disparities in cancer outcomes

Dr Camille Ragin - Fox Chase Cancer Center, Philadelphia, USA

19 Apr 2013

Vitamin D and cancer prevention

Dr Anna Woloszynska-Read

17 Apr 2013

ASCO GU: Current thinking in mCRPC

Dr Howard Scher - Memorial Sloan Kettering Cancer Center, New York

1 Mar 2013

Prediction of relapse in stage I nonseminomatous germ cell tumors by CXCL12

Dr Duncan Gilbert - Sussex Cancer Centre, Brighton , UK

25 Feb 2013

Chemo-radiotherapy for bladder cancer

Prof Nick James - University of Birmingham, UK

25 Feb 2013

TIVO 1 study shows tivozanib an option for renal cell carcinoma

Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA

25 Feb 2013

Pelvic radiotherapy and androgen blockade for high risk prostate cancer

Dr Abdenour Nabid - Sherbrooke University, Quebec, Canada

25 Feb 2013

More from ecancer